Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) Price Target at $17.97

Teladoc Health, Inc. (NYSE:TDOC) has been given a consensus recommendation of “Hold” by the eighteen brokerages that are covering the company, Marketbeat reports. Twelve research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $17.97.

Several analysts have weighed in on TDOC shares. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, April 26th. Stifel Nicolaus decreased their price objective on shares of Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 26th. TD Cowen decreased their price objective on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a research note on Friday, April 26th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Friday, April 26th. Finally, Barclays decreased their target price on shares of Teladoc Health from $25.00 to $20.00 and set an “overweight” rating for the company in a research note on Friday, April 26th.

Insider Activity

In related news, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the sale, the insider now owns 86,070 shares of the company’s stock, valued at approximately $1,092,228.30. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the transaction, the insider now directly owns 86,070 shares in the company, valued at approximately $1,092,228.30. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the transaction, the director now owns 36,995 shares in the company, valued at $440,240.50. The disclosure for this sale can be found here. Insiders sold a total of 32,592 shares of company stock valued at $397,064 in the last 90 days. 0.95% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. ICA Group Wealth Management LLC acquired a new position in Teladoc Health during the fourth quarter worth about $28,000. Hexagon Capital Partners LLC raised its stake in shares of Teladoc Health by 204.4% in the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 1,065 shares in the last quarter. RIA Advisory Group LLC bought a new position in shares of Teladoc Health in the 4th quarter valued at approximately $36,000. GAMMA Investing LLC bought a new position in Teladoc Health in the 4th quarter worth approximately $41,000. Finally, Principal Securities Inc. bought a new position in Teladoc Health in the 4th quarter worth approximately $45,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Stock Performance

Shares of NYSE:TDOC opened at $9.39 on Thursday. The firm has a fifty day simple moving average of $10.79 and a two-hundred day simple moving average of $14.92. The stock has a market capitalization of $1.59 billion, a P/E ratio of -6.66 and a beta of 0.94. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health has a 52 week low of $8.73 and a 52 week high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The company had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. During the same quarter in the previous year, the business earned ($0.37) EPS. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, analysts expect that Teladoc Health will post -1.05 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.